The U.S. Drug Enforcement Administration (DEA) has issued guidance to DEA-registered physicians providing new flexibility for physicians managing patients with opioid use disorder. The new

KMA is sharing the first-person accounts of physicians from across the state as they prepare for and battle the COVID-19 pandemic. These stories will also